Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, December 20, 2022
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
[ Tue, Dec 20th 2022
] - WOPRAI
Richard Newitter Maintained (BSX) at Strong Buy with Increased Target to $54 on, Dec 20th, 2022
Richard Newitter of Truist Securities, Maintained "Boston Scientific Corporation" (BSX) at Strong Buy with Increased Target from $50 to $54 on, Dec 20th, 2022.
Richard has made no other calls on BSX in the last 4 months.
There are 5 other peers that have a rating on BSX. Out of the 5 peers that are also analyzing BSX, 0 agree with Richard's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Richard
- Jayson Bedford of "Raymond James" Maintained at Strong Buy with Increased Target to $54 on, Thursday, December 8th, 2022
- Matt Miksic of "Barclays" Initiated at Buy and Held Target at $49 on, Tuesday, October 18th, 2022
- Matthew Taylor of "Jefferies" Initiated at Strong Buy and Held Target at $50 on, Wednesday, October 12th, 2022
- Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $50 on, Tuesday, October 11th, 2022
- Matt O'Brien of "Piper Sandler" Maintained at Buy with Increased Target to $50 on, Friday, September 9th, 2022
